Delivery Order 36C26124D0074-36C26125N0076

Award Date 10/1/24
Potential Completion Date 9/30/25
Potential Value $750K
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Reno, NV 89502, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award by the U.S. Department of Veterans Affairs (VA) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated. The $497,705.58 contract is for "CONTINGENCY HAZARDOUS PHARMACEUTICAL COMPOUNDING - RENO" and has an ultimate completion date of September 30, 2024. The contract is a Delivery Order under an Indefinite Delivery Vehicle (IDV) and has a Firm Fixed Price pricing type. Optum Pharmacy 801, Inc., operating as Avella Specialty Pharmacy,...
The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a Firm Fixed Price Purchase Order worth $148,010.43 to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract is for the provision of chemotherapy medication to support VA oncology and infusion treatment programs nationwide. The award does not have a set-aside designation. Optum Pharmacy 801, Inc. has received numerous federal contract...
This is a $458,800.00 firm fixed-price purchase order contract awarded to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, by the Department of Veterans Affairs' Veterans Integrated Service Network 2. The contract is for the provision of short-term chemotherapy and other specialized pharmaceutical compounding services to support the VA's oncology and infusion treatment programs. Optum Pharmacy 801, Inc., operating as Avella Specialty Pharmacy, is a 503A certified...
This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 (VISN 21) to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The $441,256.72 firm fixed-price delivery order is for the provision of hazardous pharmaceutical compounds to support VA oncology and infusion treatment programs in Las Vegas, Nevada. The contract has no set-aside designation and is not...
This firm fixed-price federal contract was awarded by the Department of Veterans Affairs (VA) to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The $120,000.00 contract is for chemotherapy compound services, primarily to support VA oncology and infusion treatment programs nationwide. Avella Specialty Pharmacy will provide specialized pharmaceutical services, including the preparation of customized chemotherapy agents,...
This federal contract award is for hazardous pharmaceutical compounding services provided by Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy), a subsidiary of UnitedHealth Group Incorporated. The contract, valued at $350,610.57, was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 16 (VISN 16) on a firm fixed-price basis with a completion date of September 30, 2025. Optum Pharmacy 801, Inc. has a history of securing multiple...
This federal contract award to Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy), a subsidiary of UnitedHealth Group Incorporated, is for PHARMACY COMPOUNDING services valued at $1,105,798.44. The contract supports the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) and is a Delivery Order under a Firm Fixed Price contract type. Avella, a 503A certified pharmacy, will provide specialized pharmaceutical compounding services, including chemotherapy...
This federal contract award, with an ID of 36C26025D0038|36C26025N0392, is for the "Contingency Outsourcing of Compounded Chemotherapy Medications" and was issued by the Department of Veterans Affairs (VA) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated. The contract, which is a delivery order with a firm fixed price, has a ceiling value of $500,000.00 and a period of performance ending on June 29, 2026. The contract is not set-aside and was awarded on June...
This federal contract award, valued at $230,297.50, was issued by the Department of Veterans Affairs Veterans Health Administration (VA-VHA) to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract is for the delivery of sterile compound supply services to support VA oncology and infusion treatment programs nationwide. As the prime contractor, Avella Specialty Pharmacy will compound customized chemotherapy and other...
This federal contract award is for HAZARDOUS PHARMACY COMPOUNDING SERVICES - OPTION YEAR ONE, awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 15 to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy. The contract has a ceiling value of $650,000.00 and is a Blanket Purchase Agreement (BPA) call, with a firm fixed-price pricing type. The contract is not associated with any set-aside designation. Optum Pharmacy 801, Inc. is a...
  • 36C26124D0074
    Indefinite Delivery Contract
  • 36C26124D0074-36C26125N0076
    Delivery Order

The Department of Veterans Affairs (VA) awarded a $750,000.00 firm fixed-price delivery order contract to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, for contingency hazardous pharmaceutical compounding services in Reno, Nevada. This contract is not associated with any set-aside designation.

Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, is a leading provider of specialized pharmacy services to the VA, including compounding customized chemotherapy agents, hazardous sterile preparations, intravenous solutions, and other medications based on patient-specific orders. The company has received multiple Indefinite Delivery Vehicles (IDVs) from the VA-Veterans Health Administration (VHA) to support oncology and infusion treatment programs nationwide, with contract ceiling values ranging from $500,000 to $10 million. This specific $750,000.00 delivery order is part of Avella's broader portfolio of hazardous compounding and chemotherapy services contracts with the VA.

Generated 1/11/25, 9:03 AM